As of Dec 14
| -0.02 / -0.02%|
The 8 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 140.00, with a high estimate of 145.00 and a low estimate of 120.00. The median estimate represents a +9.58% increase from the last price of 127.76.
The current consensus among 9 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.